{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:49:23Z","timestamp":1789487363830,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The genetic architecture of late-onset autosomal dominant polycystic kidney disease (ADPKD) remains incompletely defined. Pathogenic mutations in two genes that encode polycystin proteins, PKD1 and PKD2, prevail among these patients. Detection of PKD1 alterations by a sequencing method is challenging as this is a large gene with high GC content and multiple pseudogenes. Although next-generation sequencing (NGS) has become the cornerstone of molecular diagnosis, its limited availability in several settings and its limited sensitivity for structural variants may create a diagnostic blind spot, particularly for PKD2. Because PKD2-associated ADPKD follows a milder clinical course with delayed progression to end-stage renal disease (ESRD), its contribution to late-onset disease may be systematically underestimated. We hypothesized that a phenotype-driven strategy integrating copy number analysis would uncover clinically relevant PKD2 variants overlooked by DNA sequencing methods. Materials and Methods: Six well-characterized consecutive ADPKD patients that entered KRT (kidney replacement therapy) above 70 years old underwent targeted PKD2 analysis using bidirectional Sanger DNA sequencing of all coding exons and exon\u2013intron boundaries, complemented by multiplex ligation-dependent probe amplification (MLPA) for copy number variant detection. Results: Pathogenic PKD2 variants were identified in 33% of the patients in this limited cohort. These included the recurrent nonsense variant p.Arg872Ter and a previously undescribed multi-exonic deletion encompassing exons 1\u20139 that was detectable exclusively by MLPA. Additionally a novel variant of unknown significance (VUS) (p.Leu273Gln) was detected. The high diagnostic yield in this phenotypically highly enriched cohort highlights the value of targeted structural variant analysis. Conclusions: Our findings identify structural PKD2 variation as an under-recognized cause of genetically unresolved late-onset ADPKD and demonstrate that phenotype-guided incorporation of copy number analysis can overcome limitations of NGS alone. A combined sequencing\u2013MLPA approach may therefore provide a more complete and clinically informative molecular diagnosis, particularly in carefully selected patients with late-onset ADPKD.<\/jats:p>","DOI":"10.3390\/medicina62091771","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:33:42Z","timestamp":1789479222000},"page":"1771","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Sequencing: Integrating MLPA Reveals Hidden Structural PKD2 Variants and Enhances Mutation Detection in a Highly Selected ADPKD Greek Cohort"],"prefix":"10.3390","volume":"62","author":[{"given":"Akrivi","family":"Papachristopoulou","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Margoni","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimilios Christos","family":"Simoudis","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristea","family":"Mylona","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga-Irini","family":"Kroupi","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-5267","authenticated-orcid":false,"given":"Petros","family":"Nikolopoulos","sequence":"additional","affiliation":[{"name":"Nephrology Unit, 2nd Department of Internal Medicine, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios V.","family":"Vlahakos","sequence":"additional","affiliation":[{"name":"Nephrology Unit, 2nd Department of Internal Medicine, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-2599","authenticated-orcid":false,"given":"Christos","family":"Kroupis","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (2002). Polycystic kidney disease, autosomal dominant. GeneReviews\u00ae, University of Washington."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0011-5029(05)80007-0","article-title":"Polycystic kidney disease: Etiology, pathogenesis, and treatment","volume":"41","author":"Martinez","year":"1995","journal-title":"Dis. Mon."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2025.0310","article-title":"Autosomal dominant polycystic kidney disease: A review","volume":"333","author":"Chebib","year":"2025","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: A position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0043-57268","article-title":"Renal cell carcinoma in the background of autosomal dominant polycystic kidney disease: Report of two cases and review of literature","volume":"45","author":"Vias","year":"2024","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000536245","article-title":"Prevalence of renal neoplasia in autosomal dominant polycystic kidney disease: Systematic review and meta-analysis","volume":"148","author":"Drake","year":"2024","journal-title":"Nephron"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gft521","article-title":"Defective metabolism in polycystic kidney disease: Potential for therapy and open questions","volume":"29","author":"Rowe","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","article-title":"Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease","volume":"17","author":"Harris","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109626","DOI":"10.1016\/j.cellsig.2020.109626","article-title":"Structure and function of polycystin channels in primary cilia","volume":"72","author":"Ta","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eaat9819","DOI":"10.1126\/science.aat9819","article-title":"Structure of the human PKD1-PKD2 complex","volume":"361","author":"Su","year":"2018","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"(2025). Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD). Kidney Int., 107, S1\u2013S239.","DOI":"10.1016\/j.kint.2024.07.009"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1093\/ckj\/sfaf331","article-title":"Genetic testing in autosomal dominant polycystic kidney disease: Why it matters in 2025","volume":"18","author":"Ong","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Torres","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ekir.2020.12.016","article-title":"Characteristics of patients with end-stage kidney disease in ADPKD","volume":"6","author":"Shukoor","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease","volume":"27","author":"Heyer","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e138724","DOI":"10.1172\/jci.insight.138724","article-title":"The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD","volume":"5","author":"Lavu","year":"2020","journal-title":"JCI Insight"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.ekir.2024.07.012","article-title":"Biomarkers of kidney disease progression in ADPKD","volume":"9","author":"Ghanem","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/humu.1145","article-title":"Mutations of the human polycystic kidney disease 2 (PKD2) gene","volume":"18","author":"Deltas","year":"2001","journal-title":"Hum. Mutat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/geno.1997.4851","article-title":"Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2)","volume":"44","author":"Hayashi","year":"1997","journal-title":"Genomics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.2754005","article-title":"novoSNP, a novel computational tool for sequence variation discovery","volume":"15","author":"Weckx","year":"2005","journal-title":"Genome Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41581-026-01070-4","article-title":"Future needs for clinical trials in autosomal dominant polycystic kidney disease","volume":"22","author":"Kuo","year":"2026","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.34067\/KID.0000001109","article-title":"Emerging therapies in autosomal dominant polycystic kidney disease","volume":"7","author":"Chen","year":"2025","journal-title":"Kidney360"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/jtim-2024-0021","article-title":"Gene therapy in polycystic kidney disease: A promising future","volume":"12","author":"Xue","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MNH.0000000000001030","article-title":"Prospects for gene therapy in polycystic kidney disease","volume":"34","author":"Chakraborty","year":"2025","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.ymthe.2025.08.026","article-title":"In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease","volume":"33","author":"Ibel","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.pmbts.2024.07.020","article-title":"Advances in CRISPR-Cas systems for kidney diseases","volume":"210","author":"Puri","year":"2025","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.2147\/JIR.S506760","article-title":"Gene editing: An effective tool for the future treatment of kidney disease","volume":"18","author":"Cao","year":"2025","journal-title":"J. Inflamm. Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1771\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:55:01Z","timestamp":1789480501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091771"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091771","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}